Glaxosmithkline | Capitaux D'Emprunt



Loan Capital Changement Date
AbbVie USD 64.53B 4.19B 2025-03
Amgen USD 53.76B 253M 2025-06
AstraZeneca USD 25.99B 1.9B 2025-06
Aurora Cannabis CAD 41.68M 542K 2024-12
Bausch Health Companies USD 20.86B 369M 2025-06
Bristol-Myers Squibb USD 44.47B 1.69B 2025-06
Canopy Growth CAD 467.93M 34.44M 2024-12
Corcept Therapeutics USD 0 0 2025-03
Drreddys Laboratories INR 7.58B 218M 2024-12
Eli Lilly USD 34.18B 319.4M 2025-06
GlaxoSmithKline GBP 15.3B 1.17B 2025-06
Glaxosmithkline GBP 14.64B 1.39B 2024-12
J&J USD 38.36B 7.7B 2025-03
Merck USD 33.97B 484M 2025-06
Novartis USD 24.06B 2.4B 2025-06
Pacira USD 378.1M 3.2M 2025-06
Perrigo USD 3.62B 24.2M 2025-06
Pfizer USD 57.5B 137M 2025-06
Prestige Brands USD 1.01B 256K 2025-06
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 13.2B 211M 2025-06
Supernus Pharmaceuticals USD 0 0 2024-12
Takeda JPY 4.13T 168.47B 2025-06
Teva Pharmaceutical Industries USD 16.76B 533M 2025-06
Zoetis USD 5.23B 4M 2025-06


Glaxosmithkline Capitaux D'Emprunt - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.